Ratio of baseline erythropoietin (EPO) l
โ
Navapun Charuruks; Narin Voravud; Wacharee Limpanasithikul
๐
Article
๐
2001
๐
John Wiley and Sons
๐
English
โ 107 KB
## Abstract Purpose: Recently, recombinant human erythropoietin (rhEPO) was introduced for the management of anemia in malignancy. To identify an indicator for a favourable response to rhEPO, 28 anaemic cancer patients undergoing chemotherapy and treated with rhEPO were evaluated. Methods: Patients